Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.
- V. Rao, J. Dahlheimer, +4 authors D. Piwnica-Worms
- Biology, Medicine
- Proceedings of the National Academy of Sciences…
- 30 March 1999
The blood-brain barrier and a blood-cerebrospinal-fluid (CSF) barrier function together to isolate the brain from circulating drugs, toxins, and xenobiotics. The blood-CSF drug-permeability barrier… Expand
Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
- R. A. Finch, M. Liu, +5 authors A. Sartorelli
- Biology, Medicine
- Biochemical pharmacology
- 15 April 2000
Previous studies from our laboratories have shown that (a) Triapine() is a potent inhibitor of ribonucleotide reductase activity and (b) hydroxyurea-resistant L1210 leukemia cells are fully sensitive… Expand
Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione.
- A. Lorico, G. Rappa, R. A. Finch, Dianer Yang, R. Flavell, A. Sartorelli
- Biology, Medicine
- Cancer research
- 1 December 1997
The mrp (multidrug resistance protein) gene has been associated with the multidrug resistance of cancer cells in vitro and in vivo. To gain information on its physiological role, embryonic stem cells… Expand
Teratogenic assessment of four solvents using the frog embryo teratogenesis assay—xenopus (FETAX)
- T. H. Dresser, E. R. Rivera, F. Hoffmann, R. A. Finch
- Chemistry, Medicine
- Journal of applied toxicology : JAT
- 1 February 1992
The Frog Embryo Teratogenesis Assay—Xenopus (FETAX) was used to assess the teratogenic potential of four solvents. Embryos of the South African clawed frog, Xenopus laevis, were exposed for 96 h to… Expand
Phase III interlaboratory study of FETAX part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system
- J. Bantle, R. A. Finch, +4 authors A. M. Gaudet-Hull
- Medicine
- Journal of applied toxicology : JAT
- 1 November 1999
FETAX (Frog Embryo Teratogenesis Assay—Xenopus) is a 96‐h whole‐embryo developmental toxicity screening assay that can be used in ecotoxicology and in detecting mammalian developmental toxicants when… Expand
Nucleolar localization of nucleophosmin/B23 requires GTP.
- R. A. Finch, G. R. Revankar, P. Chan
- Medicine, Biology
- The Journal of biological chemistry
- 15 March 1993
Incubation of HeLa cells with the IMP dehydrogenase inhibitors: ribavirin (100 microM, 4 h), tiazofurin (100 microM, 4 h), selenazofurin (100 microM, 4 h), or mycophenolic acid (10 microM, 4 h)… Expand
Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity.
- R. A. Finch, M. Liu, A. Cory, J. Cory, A. Sartorelli
- Chemistry, Medicine
- Advances in enzyme regulation
- 1 July 1999
The enzyme RR catalyzes the conversion of ribonucleoside diphosphates to their deoxyribonucleotide counterparts. RR is critical for the generation of the cytosine, adenine, and guanine… Expand
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
- R. A. Finch, K. Shyam, P. Penketh, A. Sartorelli
- Medicine
- Cancer research
- 1 April 2001
Our laboratory has synthesized and evaluated the anticancer activity of a number of sulfonylhydrazine DNA modifying agents. As a class, these compounds possess broad spectrum antitumor activity,… Expand
Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate.
- S. Ally, T. Clair, +5 authors Y. S. Cho-Chung
- Biology, Medicine
- Cancer research
- 15 October 1989
Site-selective cyclic AMP (cAMP) analogues inhibit growth and induce changes in morphology in a spectrum of human cancer cell lines (D. Katsaros et al., FEBS Lett., 223:97, 1987). The cellular events… Expand
New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models.
- G. Rappa, R. A. Finch, A. Sartorelli, A. Lorico
- Biology, Medicine
- Biochemical pharmacology
- 15 August 1999
Growing interest in the MRP (multidrug resistance protein) gene stems from its importance in multidrug resistance to chemotherapy, its possible use in gene therapy, and its relationship with the… Expand